| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/16/2011 | CA2783740A1 Monoclonal antibodies that bind b7h6 and uses thereof |
| 06/16/2011 | CA2783691A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/16/2011 | CA2783678A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783654A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783651A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783610A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783563A1 Anti-inflammatory antibodies and uses therefor |
| 06/16/2011 | CA2783514A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783513A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/16/2011 | CA2783338A1 Anti-c4.4a antibodies and uses thereof |
| 06/16/2011 | CA2782420A1 Human antigen binding proteins that bind .beta.-klotho, fgf receptors and complexes thereof |
| 06/16/2011 | CA2781796A1 Antibody that binds to h-1 parvovirus |
| 06/16/2011 | CA2781050A1 Pcsk9 antagonists |
| 06/16/2011 | CA2780692A1 Antibodies binding preferentially human csf1r extracellular domain 4 and their use |
| 06/16/2011 | CA2780069A1 Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration |
| 06/15/2011 | EP2333099A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333098A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333097A2 Enzymes having alpha amylase activity and methods of use thereof |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2333066A1 Method for isolation of soluble polypeptides |
| 06/15/2011 | EP2333065A1 Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1 |
| 06/15/2011 | EP2333064A1 Nucleotide and protein sequences of Nogo genes and methods based thereon |
| 06/15/2011 | EP2332996A1 Protein Purification |
| 06/15/2011 | EP2332995A1 Neutralizing prolactin receptor antibodies and their therapeutic use |
| 06/15/2011 | EP2332994A1 Trispecific therapeutics against acute myeloid leukaemia |
| 06/15/2011 | EP2332993A1 Human monoclonal antibody to the human epidermal growth factor receptor |
| 06/15/2011 | EP2332992A1 Receptor coupling agents and therapeutic uses thereof |
| 06/15/2011 | EP2332991A2 Humanized anti-cd4 antibody with immunosuppressive properties |
| 06/15/2011 | EP2332990A1 Human anti-epidermal growth factor receptor antibody |
| 06/15/2011 | EP2332989A1 Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same |
| 06/15/2011 | EP2332988A2 Monoclonal antibodies and methods for their use in the detection of cervical disease |
| 06/15/2011 | EP2332987A1 Anti-inflammatory agents directed against citrullinated epitopes |
| 06/15/2011 | EP2332986A1 Antibody that binds to H-1 parvovirus |
| 06/15/2011 | EP2332985A2 Fc variants with altered binding to FcRn |
| 06/15/2011 | EP2332983A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332982A1 Liver X receptor alpha splicing mutant protein, gene thereof and utilization of the same |
| 06/15/2011 | EP2332981A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332980A2 Identification of tumor-associated cell-surface antigens for diagnosis and theapy |
| 06/15/2011 | EP2332979A2 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/15/2011 | EP2332978A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332976A1 Novel polypeptides involved in immune response |
| 06/15/2011 | EP2332975A1 Human proteins |
| 06/15/2011 | EP2332974A2 Osteoprotegerin |
| 06/15/2011 | EP2332973A2 Differential in tumour gene products and use of same |
| 06/15/2011 | EP2332972A1 Novel Beta-Actin and RPS21 promoters and uses thereof |
| 06/15/2011 | EP2332579A2 Antibodies that bind human interleukin-18 and methods of making and using |
| 06/15/2011 | EP2332577A1 Novel use of IL-1beta compounds |
| 06/15/2011 | EP2332576A1 Immunotherapy of B-cell malignancies using anti-CD22 antibody conjugates |
| 06/15/2011 | EP2332575A1 Treatment of cancer with novel anti-IL 13 monoclonal antibodies |
| 06/15/2011 | EP2332572A1 Nucleic acid vaccines for prevention of Flavivirus |
| 06/15/2011 | EP2332565A1 Low dose methods for treating disorders in which TNFalpha activity is detrimental |
| 06/15/2011 | EP2332561A1 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling |
| 06/15/2011 | EP2331689A1 Method for cloning avian-derived antibodies |
| 06/15/2011 | EP2331580A1 Multifunctional linker protein containing an antibody against hemagglutinin, a conserved influenza antigen and an immunostimulating carrier binding domain |
| 06/15/2011 | EP2331579A2 Monoclonal antibodies |
| 06/15/2011 | EP2331578A1 Novel compositons and methods for treating ige-mediated disorders |
| 06/15/2011 | EP2331577A2 Recombinant anti-epidermal growth factor receptor antibody compositions |
| 06/15/2011 | EP2331576A1 Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers |
| 06/15/2011 | EP2331575A1 Antibodies against human il 17 and uses thereof |
| 06/15/2011 | EP2331574A2 Antibodies with mannose binding lectin effector function for inhibiting pathologic inflammatory conditions |
| 06/15/2011 | EP2331573A1 Hepatitis c antibodies and uses thereof |
| 06/15/2011 | EP2331572A1 Pharmaceutical compositions comprising antibodies binding to the intracellular domain of ebv (epstein-barr virus) latent membrane protein-1 (lmp1) |
| 06/15/2011 | EP2331571A1 Nmda receptor modulators and uses thereof |
| 06/15/2011 | EP2331570A1 Display library for antibody selection |
| 06/15/2011 | EP2331565A2 Hiv-1 envelope polypeptides for hiv vaccine |
| 06/15/2011 | EP2331136A2 Frizzled-binding agents and uses thereof |
| 06/15/2011 | EP2331134A2 Anti-pancreatic cancer antibodies |
| 06/15/2011 | EP2331133A2 Anti-lipid antibodies |
| 06/15/2011 | EP2331131A1 Treating cancer by modulating rna helicases |
| 06/15/2011 | EP2331130A2 Ige antibodies for the treatment of cancer |
| 06/15/2011 | EP2331119A1 Malaria vaccine |
| 06/15/2011 | EP2331107A1 Vhz for diagnosis and treatment of cancers |
| 06/15/2011 | EP2331078A1 Lyophilized formulatons of engineered anti-il-23p19 antibodies |
| 06/15/2011 | EP2142570B1 Anti-epcam antibody and uses thereof |
| 06/15/2011 | EP1974020B1 Methods for obtaining immortalized antibody secreting cells |
| 06/15/2011 | EP1881008B1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 06/15/2011 | EP1766093B1 Antibodies against clostridium difficile toxins and uses thereof |
| 06/15/2011 | EP1751189B1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 06/15/2011 | EP1749030B1 A diabody which specifically binds streptococcus surface antigen i/ii and methods of use thereof |
| 06/15/2011 | EP1500665B1 METHODS FOR CONSTRUCTING scDb LIBRARIES |
| 06/15/2011 | EP1438401B1 Production of a transgenic avian by cytoplasmic injection |
| 06/15/2011 | EP1404710B1 Identification of ses-3 (spr-5) in c. elegans and the uses of the same |
| 06/15/2011 | EP1282722B1 Stabilized proteins |
| 06/15/2011 | EP1012274B2 Death domain containing receptor 4 (dr4: death receptor 4), member of the tnf-receptor superfamily and binding to trail (ap0-2l) |
| 06/15/2011 | EP0939804B2 NEUTROKINE alpha |
| 06/15/2011 | EP0853647B2 Fluorinated xanthene derivatives |
| 06/15/2011 | CN1849135B Methods for treating interleukin-6-related diseases |
| 06/15/2011 | CN1820734B Treatment with anti-erbb2 antibodies |
| 06/15/2011 | CN1780907B Anti-CCR5 antibody |
| 06/15/2011 | CN1680432B Viral protein |
| 06/15/2011 | CN1452636B Human monoclonal antibodies to dendritis cells |
| 06/15/2011 | CN102099470A Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 06/15/2011 | CN102099468A Anti-system ASC amino acid transporter 2 (ASCT2) antibody |
| 06/15/2011 | CN102099378A Amino acid sequences directed against cxcr4 and other gpcrs and compounds comprising the same |
| 06/15/2011 | CN102099377A CD37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| 06/15/2011 | CN102099376A Antibodies against extracellular domains 2 and 3 or her2 |
| 06/15/2011 | CN102099374A Methods and compositions for modulating angiogenesis and pericyte composition |
| 06/15/2011 | CN102099373A Multivalent fibronectin based scaffold domain proteins |
| 06/15/2011 | CN102095852A Double-antibody sandwich method for quickly detecting novel H1N1 influenza virus |
| 06/15/2011 | CN102094035A Expression vector for constructing high-quality bacteriophage antibody library |